The invention relates to the technical field of immunocyte
targeting therapy, in particular to an optimized kit
system and application for separating and purifying memory immune cells (TCM) or CD8T+ cells from human
peripheral blood or
peripheral blood mononuclear cells, a TCM induction and amplification kit and a kit for product
quality control and identification. In clinical application, TCM cells were cultured with many reagents, inconsistent standards, as that culture process has the advantages of large
workload, long culture time, tedious process,
instability, high
contamination risk anddifficult control of
cell quality standards, it is difficult for many technicians to culture TCM
cell with
uniform quality in a short period of time, and it is urgent to develop a simple and formattedkit. Meanwhile, the invention further optimizes the
inducer composition TCM-III, the
raw material is saved and the production cost is reduced; TCM-II-coated culture plate increased the proliferationof TCM cells by 2-3 times, the apoptotic index decreased, and the activity is increased by 10%-20%, the
absolute number of effective cells increased by 2-3 times; before TCR
gene transfection, TCM-II-coated culture plate can improve the
transfection efficiency. The invention improves the process, which has important significance for clinically improving the
curative effect of tumor treatment, removing residual lesions, and preventing the recurrence and
metastasis of tumor.